# US 2015/0105376 A1 · Quinolinone carboxamide inhibitors of endothelial lipase

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0105376 A1
- Document ID: US20150105376A1
- Status: Published application
- Kind: A1
- Application number: 14/575,203
- Filed: 2014-12-18
- Published: 2015-04-16
- Earliest claimed: 2011-09-30
- Assignees: Bristol-Myers Squibb Company
- Applicants: Bristol-Myers Squibb Company
- Inventors: Jennifer X. Qiao; Carol Hui Hu; Tammy C. Wang
- Web page: https://patentgrep.com/patent/US20150105376A1

## CPC

- C07D 215/50: attached in position 4
- A61P 3/06: Antihyperlipidemics
- C07D 215/22: attached in position 2 or 4
- C07D 215/54: attached in position 3
- C07D 401/12: linked by a chain containing hetero atoms as chain links
- C07D 401/14: containing three or more hetero rings
- C07D 403/12: linked by a chain containing hetero atoms as chain links
- C07D 413/12: linked by a chain containing hetero atoms as chain links
- C07D 417/12: linked by a chain containing hetero atoms as chain links
- C07D 417/14: containing three or more hetero rings
- C07D 419/12: linked by a chain containing hetero atoms as chain links
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides compounds of Formula (I): as defined in the specification and compositions comprising any of such novel compounds. These compounds are endothelial lipase inhibitors which may be used as medicaments.

## Claims

### Claim 1

A compound of Formula (I):
or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, wherein:
R1 is independently selected from the group consisting of: H, C1-6 alkyl substituted with 0-3 Ra, C2-6 alkenyl substituted with 0-3 Ra, and —(CH2)n—W—(CH2)m—R1a;
W is independently selected from the group consisting of: a bond, NH, O, S, N(C1-4 alkyl), CO, CONH, CON(C1-4 alkyl), NHCO, SO2, NHSO2, SO2NH, NHCO2, and CHRf;
R1a is independently selected from the group consisting of: C3-10 carbocycle and a 5- to 10-membered heterocycle comprising: carbon atoms and 1-4 heteroatoms selected from N, NRe, O, and S(O)p; and wherein said carbocycle and heterocycle are substituted with 0-3 Rc;
R2a, R2b, R2c, and R2d are, independently at each occurrence, selected from the group consisting of: H, halogen, OH, C1-4 alkyl, C1-2 alkenyl, C1-4 haloalkyl, C1-4 alkoxy, C1-4 haloalkoxy, CF3, OCF3, OCF2CHF2, CN, NH2, NO2, NH(C1-4 alkyl), N(C1-4 alkyl)2, CO2H, CO2(C1-4 alkyl), CONH2, CONH(C1-4 alkyl), CON(C1-4 alkyl)2, NHSO2(C1-4 alkyl), SO2(C1-4 alkyl), SO2NH2, and phenyl substituted with 0-2 Rb;
R4 is independently selected from the group consisting of: C3-10 carbocycle and a 5- to 10-membered heterocycle comprising: carbon atoms and 1-4 heteroatoms selected from N, NRe, O, and S(O)p; wherein said carbocycle and heterocycle are substituted with 0-3 Rd;
R5 is independently selected from the group consisting of: OR6, CN, and NR7R8;
R6 is independently selected from the group consisting of: H and C1-6 alkyl substituted with 0-1 CO2H;
R7 is independently selected from the group consisting of: H, C1-6 alkyl substituted with 0-1 Ra, —(CH2)n-(phenyl substituted with 0-3 Rb), and —(CH2)n-(5- to 6-membered heterocycle comprising: carbon atoms and 1-4 heteroatoms selected from N, NRe, O, and S(O)p); and wherein said heterocycle is substituted with 0-3 Rc;
R8 is independently selected from the group consisting of: H and C1-6 alkyl;
alternatively, NR7R8 is a 5- to 6-membered heterocycle comprising: carbon atoms and 1-4 heteroatoms selected from N, NRe, O, and S(O)p;
L is independently a hydrocarbon or hydrocarbon-heteroatom linker optionally substituted with 0-2 Rg; wherein said hydrocarbon linker has one to eight carbon atoms and may be straight or branched, saturated or unsaturated; and said hydrocarbon-heteroatom linker has one to seven carbon atoms and one group selected from O, —CO—, S, —SO—, —SO2—, NH, and N(C1-4 alkyl);
alternatively, L is X1—Y—X2;
X1, and X2 are, independently at each occurrence, selected from the group consisting of: a bond, a hydrocarbon linker and a hydrocarbon-heteroatom linker; wherein said hydrocarbon linker and hydrocarbon-heteroatom linker may be substituted with 0-2 Rg; said hydrocarbon linker has one to six carbon atoms and may be saturated or unsaturated; and said hydrocarbon-heteroatom linker may be saturated or unsaturated and has zero to four carbon atoms and one group selected from O, —CO—, S, —SO—, —SO2—, NH, and N(C1-4 alkyl);
Y is independently selected from the group consisting of: C3-10 carbocycle and a 4- to 10-membered heterocycle comprising: carbon atoms and 1-4 heteroatoms selected from N, NRe, O, and S(O)p; wherein each said carbocycle and heterocycle may be optionally substituted with one, two or three substituents independently selected from: halogen, OH, C1-4 alkyl, C1-4 haloalkyl, and C1-4 alkyoxy;
alternatively, R4-L- is
Ra is, independently at each occurrence, selected from the group consisting of: halogen, OH, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, CF3, OCF3, CN, NH2, NO2, NH(C1-4 alkyl), N(C1-4 alkyl)2, CO2H, CO2(C1-4 alkyl), NHCO(C1-4 alkyl substituted with 0-1 NH2), N(C1-4 alkyl)CO(C1-4 alkyl), NHCO2(C1-4 alkyl), CONHSO2(C1-4 alkyl), SO2(C1-4 alkyl), CONH2, CONH(C1-4 alkyl), NHSO2(C1-4 alkyl), N(C1-4 alkyl)SO2(C1-4 alkyl), and phenoxy;
Rb is, independently at each occurrence, selected from the group consisting of: halogen, OH, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, CF3, OCF3, OCF2CHF2, OCH2CF3, CN, NH2, NO2, NH(C1-4 alkyl), N(C1-4 alkyl)2, CO2H, CO2(C1-4 alkyl), CONH2, CONH(C1-4 alkyl), CON(C1-4 alkyl)2, NHCO2(C1-4 alkyl),
NHSO2(C1-4 alkyl), N(C1-4 alkyl)SO2(C1-4 alkyl), SO2(C1-4 alkyl), SO2NH2, phenyl, benzyl, and phenoxy;
Rc is, independently at each occurrence, selected from the group consisting of: ═O and Rb;
Rd is, independently at each occurrence, selected from the group consisting of: ═O, halogen, OH, C1-6 alkyl substituted with 0-1 OH, C1-4 alkoxy, C1-4 haloalkyl, C1-4 haloalkoxy, CF3, OCF3, OCF2CF2H, OCH2CF3, CN, NH2, NO2, NH(C1-4 alkyl), N(C1-4 alkyl)2, CO2H, CO2(C1-4 alkyl), CO(C1-4 alkyl), NHCO(C1-4 alkyl), —CH2NHCO(C1-4 alkyl), CONH2, CONH(C1-4 alkyl), CON(C1-4 alkyl)2, SO2(C1-4 alkyl), SO2NH2, —SO2NH(C1-4 alkyl), —SO2NH(C3-6 cycloalkyl), —NHSO2(C1-4 alkyl), —CH2NHSO2(C1-4 alkyl), Si(C1-4 alkyl)3, and phenyl optionally substituted with one or two substituents independently selected from: halogen, OH, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkyoxy, and NHCO(C1-4 alkyl);
Re is, independently at each occurrence, selected from the group consisting of: H, C1-4 alkyl, CO(C1-4 alkyl), CO2(C1-4 alkyl), CO2(benzyl), and —(CH2)n-(phenyl optionally substituted with 0-2 halogens);
Rf is, independently at each occurrence, selected from the group consisting of: C1-4 alkyl, C2-4 alkenyl, CO2(C1-4 alkyl), CONH2, C3-6 cycloalkyl, phenyl, and benzyl;
Rg is, independently at each occurrence, selected from the group consisting of: halogen, OH, C1-4 alkyl, C2-4 alkenyl, C1-4 haloalkyl, C1-4 alkyoxy, CO2(C1-4 alkyl), C3-6 cycloalkyl, and phenyl;
m is, independently at each occurrence, selected from 0, 1, and 2;
n is, independently at each occurrence, selected from 0, 1, 2, 3, and 4; and
p is, independently at each occurrence, selected from 0, 1, and 2;
provided that: when L is CH2, R1 is H and R5 is OH, then R4 is other than an unsubstituted phenyl.

### Claim 2 (depends on 1)

A compound according to claim 1, wherein:
R1 is independently selected from the group consisting of: C1-6 alkyl substituted with 0-2 Ra, C2-6 alkenyl substituted with 0-2 Ra, and —(CH2)n—W—R1a;
W is independently selected from the group consisting of: a bond, NH, N(C1-4 alkyl), CO, CONH, CON(C1-4 alkyl), SO2, NHCO2, and CHRf;
R1a is independently selected from the group consisting of: C3-6 cycloalkyl substituted with 0-3 Rc, phenyl substituted with 0-3 Rb, naphthyl substituted with 0-2 Rb, tetrahydronaphthyl substituted with 0-2 Rb, dihydroindenyl substituted with 0-2 Rc, and a 5- to 10-membered heterocycle comprising: carbon atoms and 1-4 heteroatoms selected from N, NRe, O, and S(O)p; and wherein said heterocycle is substituted with 0-3 Rc;
R2a, R2b and R2c are, independently at each occurrence, selected from the group consisting of: H, halogen, OH, C1-4 alkyl, C1-2 alkenyl, C1-4 haloalkyl, C1-4 alkoxy, CF3, OCF3, OCF2CHF2, OCH2CF3, OCF2CF3, OCH2CF2CF3, NH2, NO2, NH(C1-4 alkyl), N(C1-4 alkyl)2, CO2H, CO2(C1-4 alkyl), CONH2, CONH(C1-4 alkyl), CON(C1-4 alkyl)2, NHSO2(C1-4 alkyl), SO2(C1-4 alkyl), SO2NH2, and phenyl substituted with 0-2 Rb;
R2d is independently selected from the group consisting of: H, halogen, OH, C1-4 alkyl, and NH2;
R4 is independently selected from the group consisting of: C5-6 cycloalkyl, phenyl, naphthyl, tetrahydronaphthyl, dihydroindenyl, and a 5- to 10-membered heterocycle comprising: carbon atoms and 1-4 heteroatoms selected from N, NRe, O, and S(O)p; and wherein each moiety is substituted with 0-3 Rd;
R5 is independently selected from the group consisting of: OH, O(C1-4 alkyl substituted with 0-1 CO2H), CN, and NR7R8;
L is independently a hydrocarbon or hydrocarbon-heteroatom linker optionally substituted with 0-1 Rg; wherein said hydrocarbon linker has one to six carbon atoms and may be straight or branched, saturated or unsaturated; and said hydrocarbon-heteroatom linker has one to five carbon atoms and one group selected from O, —CO—, S, —SO—, —SO2—, NH, and N(C1-4 alkyl);
alternatively, L is X1—Y—X2;
X1, and X2 are, independently at each occurrence, selected from the group consisting of: a bond, a hydrocarbon linker and a hydrocarbon-heteroatom linker; wherein said hydrocarbon linker and hydrocarbon-heteroatom linker may be substituted with 0-1 Rg; said hydrocarbon linker may be saturated or unsaturated and has one to five carbon atoms; and said hydrocarbon-heteroatom linker may be saturated or unsaturated and has zero to four carbon atoms and one group selected from O, —CO—, S, —SO—, —SO2—, NH, and N(C1-4 alkyl);
Y is independently selected from the group consisting of: C3-7 carbocycle and a 4- to 10-membered heterocycle comprising: carbon atoms and 1-4 heteroatoms selected from N, NRe, O, and S(O)p; wherein each said carbocycle and heterocycle may be optionally substituted with one, two or three substituents independently selected from: halogen, OH, C1-4 alkyl, C1-4 haloalkyl, and C1-4 alkyoxy;
alternatively, R4-L- is
provided that: when L is CH2, R1 is H and R5 is OH, then R4 is other than an unsubstituted phenyl.

### Claim 3 (depends on 1)

A compound according to claim 1, wherein:
R1 is independently selected from the group consisting of: C1-6 alkyl substituted with 0-2 Ra, C2-6 alkenyl substituted with 0-2 Ra, and —(CH2)n—W—R1a;
W is independently selected from the group consisting of: a bond, CO, CONH, CON(C1-4 alkyl), SO2, and CHRf;
R1a is independently selected from the group consisting of: C3-6 cycloalkyl substituted with 0-3 Rc, phenyl substituted with 0-3 Rb, and a 5- to 6-membered heterocycle comprising: carbon atoms and 1-4 heteroatoms selected from N, NRe, O, and S(O)p; and wherein said heterocycle is substituted with 0-3 Rc;
L is independently a hydrocarbon or hydrocarbon-heteroatom linker optionally substituted with 0-1 Rg; wherein said hydrocarbon linker has one to four carbon atoms and may be straight or branched, saturated or unsaturated; and said hydrocarbon-heteroatom linker has one to four carbon atoms and one group selected from O, S, —SO—, and —SO2—;
alternatively, L is X1—Y—X2;
X1, and X2 are, independently at each occurrence, selected from the group consisting of: a bond, a hydrocarbon linker and a hydrocarbon-heteroatom linker; wherein said hydrocarbon linker and hydrocarbon-heteroatom linker may be substituted with 0-1 Rg; said hydrocarbon linker may be saturated or unsaturated and has one to five carbon atoms; and said hydrocarbon-heteroatom linker may be saturated or unsaturated and has zero to four carbon atoms and one group selected from O, —CO—, S, —SO—, —SO2—, NH, and N(C1-4 alkyl);
Y is independently selected from the group consisting of: C3-6 cycloalkylene, C4-6 cycloalkenylene, phenylene, pyridylene, azetidinylene, pyrrolidinylene, piperidinylene, pyrazolylene, thiazolylene, oxadiazolylene, imidazolylene, and benzimidazolylene; wherein said phenylene may be optionally substituted with one or two substituents independently selected from: halogen, OH, C1-4 alkyl, C1-4 haloalkyl, and C1-4 alkyoxy.

### Claim 4 (depends on 1)

A compound according to claim 1, wherein the compound is of Formula (II):
or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof, within the scope of any of the above aspects, wherein:
R1 is independently selected from the group consisting of: H, C1-4 alkyl substituted with 0-1 Ra, —(CH2)0-1CH(CH3)-(phenyl substituted with 0-2 Rb), —(CH2)0-2-(phenyl substituted with 0-3 Rb), and —(CH2)0-2-(5- to 6-membered heterocycle comprising: carbon atoms and 1-4 heteroatoms selected from N, NRe, O, and S(O)p); and wherein said heterocycle is substituted with 0-2 Rc;
R2a, R2b, and R2c are, independently at each occurrence, selected from the group consisting of: H, halogen, CF3, OCF3, OCF2CHF2, OCH2CF3, OCF2CF3, OCH2CF2CF3, CN, NH2, NO2, CONH2, C1-4 alkyl, C1-2 alkenyl, C1-4 alkoxy, and phenyl substituted with 0-2 Rc; and
R4 is independently selected from: phenyl, naphthyl, tetrahydronaphthyl, dihydroindenyl, pyrrolidinyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl, 1,2,3-thiadiazolyl, 1,2,4-oxadiazolyl, piperidinyl, piperazinyl, morpholinyl, indolinyl, quinolinyl, and benzimidazolyl; wherein each moiety is substituted with 0-2 Rd;
alternatively, R4-L- is

### Claim 5 (depends on 1)

A compound according to claim 1, wherein:
R1 is independently selected from the group consisting of: H, C1-4 alkyl, —CH2CO2(C1-4 alkyl), phenyl, 4-halo-phenyl, benzyl, 4-CO2H-benzyl, 4-SO2(C1-4 alkyl)-benzyl, 2-(C1-4 alkoxy)-5-halo-benzyl, 2-halo-phenethyl, 2-OH-phenethyl;
R2a, R2b, and R2c are, independently at each occurrence, selected from the group consisting of: H, halogen, CF3, OCF3, CN, NH2, NO2, CONH2, C1-4 alkyl, C1-2 alkenyl, C1-4 alkoxy, and phenyl substituted with 0-2 Rc;
R4 is independently selected from: phenyl, naphthyl, tetrahydronaphthyl, pyrrolidinyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl, 1,2,3-thiadiazolyl, 1,2,4-oxadiazolyl, tetrazolyl, piperidinyl, piperazinyl, morpholinyl, indolyl, indolinyl, and benzimidazolyl; wherein each moiety is substituted with 0-2 Rd;
L is independently a hydrocarbon or hydrocarbon-heteroatom linker optionally substituted with 0-1 Rg; wherein said hydrocarbon linker has one to six carbon atoms and may be straight or branched, and saturated or unsaturated; and said hydrocarbon-heteroatom linker has one to six carbon atoms and one group selected from O, —CO—, S, —SO—, —SO2—, NH, and N(C1-4 alkyl);
alternatively, L is X1—Y—X2;
X1 is independently selected from the group consisting of: a bond, a hydrocarbon linker and a hydrocarbon-heteroatom linker; wherein said hydrocarbon linker and hydrocarbon-heteroatom linker may be substituted with 0-1 Rg; said hydrocarbon linker has one to four carbon atoms and may be saturated or unsaturated; and said hydrocarbon-heteroatom linker has zero to three carbon atoms and one group selected from O, —CO—, S, —SO—, —SO2—, NH, and N(C1-4 alkyl);
X2 is independently selected from the group consisting of: a bond, a hydrocarbon linker and a hydrocarbon-heteroatom linker; wherein said hydrocarbon linker and hydrocarbon-heteroatom linker may be substituted with 0-1 Rg; said hydrocarbon linker has one to five carbon atoms and may be saturated or unsaturated; and said hydrocarbon-heteroatom linker has zero to four carbon atoms and one group selected from O, —CO—, S, —SO—, —SO2—, NH, and N(C1-4 alkyl); and
Y is independently selected from the group consisting of: C3-6 cycloalkylene, C4-6 cycloalkenylene, phenylene, pyridylene, azetidinylene, pyrrolidinylene, piperidinylene, pyrazolylene, thiazolylene, oxadiazolylene, imidazolylene, and benzimidazolylene; wherein said phenylene may be optionally substituted with one or two substituents independently selected from: halogen, OH, C1-4 alkyl, C1-4 haloalkyl, and C1-4 alkyoxy;
alternatively, R4-L- is

### Claim 6 (depends on 1)

A compound according to claim 1, wherein:
R1 is independently selected from the group consisting of: H, C1-4 alkyl, phenyl, 4-halo-phenyl, benzyl, and 2-(C1-4 alkoxy)-5-halo-benzyl;
R2a is independently selected from the group consisting of: H, halogen, CF3, OCF3, and C1-4 alkyl;
R2b is independently selected from the group consisting of: H and halogen;
R2c is independently selected from the group consisting of: H, halogen, CF3, OCF3, C1-4 alkyl, C1-4 alkoxy, CN, NH2, NO2, CONH2, and 4-halo-Ph; and
R4 is independently selected from the group consisting of: phenyl, 2-halo-phenyl, 3-halo-phenyl, 4-halo-phenyl, 3-(C1-4 alkyl)-phenyl, 4-(C1-4 alkyl)-phenyl, 2-(C1-4 alkoxy)-phenyl, 3-(C1-4 alkoxy)-phenyl, 4-(C1-4 alkoxy)-phenyl, 2-CF3-phenyl, 3-CF3-phenyl, 4-CF3-phenyl, 3-OCF3-phenyl, 4-OCF3-phenyl, 3-CO2(C1-4 alkyl)-phenyl, 4-CO2(C1-4 alkyl)-phenyl, 2-NO2-phenyl, 3-NO2-phenyl, 4-NO2-phenyl, 2-(C1-4 alkyl)-6-(C1-4 alkyl)-phenyl, 2-halo-3-halo-phenyl, 2-halo-4-halo-phenyl, 3-halo-4-halo-phenyl, 2-halo-6-halo-phenyl, 2-CF3-4-halo-phenyl, 1-naphthyl, 2-naphthyl, 1-pyrrolidinyl, 2-thienyl, 1-pyrrolyl, 1-pyrazolyl, 1,2,3-thiadiazol-4-yl, tetrazol-1-yl, 5-(C1-4 alkyl)-1,2,4-oxadiazol-3-yl, 1-piperidinyl, 3-(C1-4 alkyl)-piperidin-1-yl, 4-(C1-4 alkyl)-piperidin-1-yl, 4-OH-piperidin-1-yl, 4-phenyl-piperidin-1-yl, 4-phenyl-4-OH-piperidin-1-yl, 4-CO2(C1-4 alkyl)-piperazin-1-yl, 4-Cbz-piperazin-1-yl, 4-(C1-4 alkyl)-piperazin-1-yl, 4-CH2CH2OH-piperazin-1-yl, 4-morpholinyl, 1H-indol-4-yl,
and
L is independently selected from the group consisting of: C1-4 alkylene, —O—C2-4 alkylene-, —S—C2-4 alkylene-, —C0-2 alkylene-(1,2-phenylene)-C0-2 alkylene-, —C0-2 alkylene-(1,3-phenylene)-C0-2 alkylene-, —C0-2 alkylene-(1,4-phenylene)-C0-2 alkylene-, —NH-(1,3-phenylene)-C0-2 alkylene-, —O-(1,4-phenylene)-C0-2 alkylene-, -(1,2-phenylene)-O—C0-3 alkylene-, -(1,3-phenylene)-O—C0-3 alkylene-, -(1,4-phenylene)-O—C0-3 alkylene-, —O-(1,4-phenylene)-O—C0-3 alkylene-, —SO2-(1,4-phenylene)-C0-2 alkylene-,
wherein each said alkylene may be straight or branched;
alternatively, R4-L- is

### Claim 7 (depends on 1)

A compound according to claim 1, wherein:
R1 is independently selected from the group consisting of: H, methyl, isopropyl, isobutyl, phenyl, 4-Br-phenyl, benzyl, and 2-OCH3-5-Cl-benzyl;
R2a is independently selected from the group consisting of: H, F, CF3, OCF3, and methyl;
R2b is independently selected from the group consisting of: H and Cl;
R2c is independently selected from the group consisting of: H, F, Cl, Br, I, CF3, OCF3, methyl, methoxy, CN, NH2, NO2, CONH2, and 4-F-Ph;
R4 is independently selected from the group consisting of: phenyl, 2-F-phenyl, 3-F-phenyl, 4-F-phenyl, 2-Cl-phenyl, 3-Cl-phenyl, 4-Cl-phenyl, 3-methyl-phenyl, 4-methyl-phenyl, 2-methoxy-phenyl, 3-methoxy-phenyl, 4-methoxy-phenyl, 2-CF3-phenyl, 3-CF3-phenyl, 4-CF3-phenyl, 3-OCF3-phenyl, 4-OCF3-phenyl, 3-CO2Me-phenyl, 4-CO2Me-phenyl, 2-NO2-phenyl, 3-NO2-phenyl, 4-NO2-phenyl, 2,6-dimethyl-phenyl, 2,3-dichloro-phenyl, 2,4-dichloro-phenyl, 3,4-dichloro-phenyl, 2,6-dichloro-phenyl, 2-CF3-4-F-phenyl, 1-naphthyl, 2-naphthyl, 1-pyrrolidinyl, 2-thienyl, 1-pyrrolyl, 1-pyrazolyl, 1,2,3-thiadiazol-4-yl, 5-methyl-1,2,4-oxadiazol-3-yl, 1-piperidinyl, 4-phenyl-piperidin-1-yl, 4-phenyl-4-OH-piperidin-1-yl, 4-methyl-piperidin-1-yl, 4-Boc-piperazin-1-yl, 4-Cbz-1-piperazinyl, 4-CH2CH2OH-piperazin-1-yl, 4-morpholinyl,
and
L is independently selected from the group consisting of: —CH2—, —CH(CH3)—, —CH(CH2CH3)—, —(CH2)2—, —(CH2)3—, —(CH2)2CH(CH3)—, —OCH(CH3)CH2—, —OCH2CH(CH3)—, O(CH2)2CH(CH3)—, —O(CH2)2—, —O(CH2)3—, —O(CH2)4—, —S(CH2)3—, -(1,2-phenylene)-CH2—, -(1,3-phenylene)-CH2—, -(1,4-phenylene)-CH2—, -(1,4-phenylene)-(CH2)2—, —CH2-(1,3-phenylene)-CH2—, —CH2-(1,4-phenylene)-CH2—, -(1,3-phenylene)-CH(CH3)—, —NH-(1,3-phenylene)-CH(CH3)—, —O-(1,4-phenylene)-CH2—, -(1,2-phenylene)-O(CH2)3—, -(1,3-phenylene)-O(CH2)3—, -(1,4-phenylene)-O(CH2)3—, —O-(1,4-phenylene)-O(CH2)3—, —(CH2)2O-(1,3-phenylene)-CH2—, —SO2-(1,4-phenylene)-CH2—,
alternatively, R4-L- is

### Claim 8 (depends on 1)

A compound according to claim 1, wherein:
R1 is independently selected from the group consisting of: H, methyl, isopropyl, isobutyl, phenyl, 4-Br-phenyl, benzyl, and 2-OCH3-5-C1-benzyl;
R2a is independently selected from the group consisting of: H, F, OCF3, and methyl;
R2b is independently selected from the group consisting of: H and Cl;
R2c is independently selected from the group consisting of: H, F, Cl, Br, I, CF3, OCF3, methyl, methoxy, CN, NH2, and NO2;
R4 is independently selected from the group consisting of: phenyl, 2-F-phenyl, 3-F-phenyl, 4-F-phenyl, 2-Cl-phenyl, 4-Cl-phenyl, 3-methyl-phenyl, 4-methyl-phenyl,
2-methoxy-phenyl, 3-methoxy-phenyl, 4-methoxy-phenyl, 2-CF3-phenyl, 3-CF3-phenyl, 4-CF3-phenyl, 3-OCF3-phenyl, 4-OCF3-phenyl, 3-CO2Me-phenyl, 4-CO2Me-phenyl, 2-NO2-phenyl, 3-NO2-phenyl, 4-NO2-phenyl, 2,6-dimethyl-phenyl,
2,3-dichloro-phenyl, 2,4-dichloro-phenyl, 3,4-dichloro-phenyl, 2,6-dichloro-phenyl, 1-naphthyl, 1-pyrrolyl, 1-piperidinyl, 4-phenyl-4-OH-piperidin-1-yl, 4-Boc-piperazin-1-yl, 4-Cbz-1-piperazinyl,
and
L is independently selected from the group consisting of: —CH2—, —CH(CH2CH3)—, —(CH2)2—, —(CH2)3—, —(CH2)2CH(CH3)—, —OCH2CH(CH3)—, —O(CH2)2CH(CH3)—, —O(CH2)3—, —O(CH2)4—, —S(CH2)3—, -(1,2-phenylene)-CH2—, -(1,3-phenylene)-CH2—, -(1,4-phenylene)-CH2—, -(1,3-phenylene)-CH(CH3)—, —O-(1,4-phenylene)-CH2—, -(1,2-phenylene)-O(CH2)3—, -(1,3-phenylene)-O(CH2)3—, -(1,4-phenylene)-O(CH2)3—, —O-(1,4-phenylene)-O(CH2)3—,
alternatively, R4-L- is

### Claim 9 (depends on 1)

A compound according to claim 1, wherein:
R4 is independently selected from the group consisting of: phenyl, 2-F-phenyl, 3-F-phenyl, 4-F-phenyl, 2-Cl-phenyl, 3-Cl-phenyl, 4-Cl-phenyl, 3-methyl-phenyl, 4-methyl-phenyl, 2-methoxy-phenyl, 3-methoxy-phenyl, 4-methoxy-phenyl, 2-CF3-phenyl, 3-CF3-phenyl, 4-CF3-phenyl, 3-OCF3-phenyl, 4-OCF3-phenyl, 3-CO2Me-phenyl, 4-CO2Me-phenyl, 2-NO2-phenyl, 3-NO2-phenyl, 4-NO2-phenyl, 2,6-dimethyl-phenyl, 2,3-dichloro-phenyl, 2,4-dichloro-phenyl, 3,4-dichloro-phenyl, 2,6-dichloro-phenyl, 2-CF3-4-F-phenyl, 1-naphthyl, 2-naphthyl, and
and
L is independently selected from the group consisting of: —CH2—, —CH(CH3)—, —CH(CH2CH3)—, —(CH2)2—, —(CH2)3—, —(CH2)2CH(CH3)—, —OCH(CH3)CH2—, —OCH2CH(CH3)—, —O(CH2)2CH(CH3)—, —O(CH2)2—, —O(CH2)3—, —O(CH2)4—, and —S(CH2)3—.

### Claim 10 (depends on 1)

A compound according to claim 1, wherein:
R4 is independently selected from the group consisting of: phenyl, 4-F-phenyl, 4-Cl-phenyl, 4-methyl-phenyl, 2-CF3-phenyl, 4-CF3-phenyl, 3,4-dichloro-phenyl, 1-pyrrolidinyl, 2-thienyl, 1-pyrrolyl, 1-pyrazolyl, 1,2,3-thiadiazol-4-yl, 5-methyl-1,2,4-oxadiazol-3-yl, 1-piperidinyl, 4-phenyl-piperidin-1-yl, 4-phenyl-4-OH-piperidin-1-yl, 4-methyl-piperidin-1-yl, 4-Boc-piperazin-1-yl, 4-Cbz-1-piperazinyl, 4-CH2CH2OH-piperazin-1-yl, 4-morpholinyl, and
and
L is independently selected from the group consisting of: -(1,2-phenylene)-CH2—, -(1,3-phenylene)-CH2—, -(1,4-phenylene)-CH2—, -(1,4-phenylene)-(CH2)2—, —CH2-(1,3-phenylene)-CH2—, —CH2-(1,4-phenylene)-CH2—, -(1,3-phenylene)-CH(CH3)—, —NH-(1,3-phenylene)-CH(CH3)—, —O-(1,4-phenylene)-CH2—, -(1,2-phenylene)-O(CH2)3—, -(1,3-phenylene)-O(CH2)3—, -(1,4-phenylene)-O(CH2)3—, —O-(1,4-phenylene)-O(CH2)3—, —(CH2)2O-(1,3-phenylene)-CH2—, —SO2-(1,4-phenylene)-CH2—,
alternatively, R4-L- is

### Claim 11 (depends on 1)

A compound according to claim 1, wherein:
R4 is independently selected from the group consisting of: phenyl, 2-F-phenyl, 3-F-phenyl, 4-F-phenyl, 2-Cl-phenyl, 4-Cl-phenyl, 3-methyl-phenyl, 4-methyl-phenyl,
2-methoxy-phenyl, 3-methoxy-phenyl, 4-methoxy-phenyl, 2-CF3-phenyl, 3-CF3-phenyl, 4-CF3-phenyl, 3-OCF3-phenyl, 4-OCF3-phenyl, 3-CO2Me-phenyl, 4-CO2Me-phenyl, 2-NO2-phenyl, 3-NO2-phenyl, 4-NO2-phenyl, 2,6-dimethyl-phenyl,
2,3-dichloro-phenyl, 2,4-dichloro-phenyl, 3,4-dichloro-phenyl, 2,6-dichloro-phenyl, 1-naphthyl, and
and
L is independently selected from the group consisting of: —CH2—, —CH(CH2CH3)—, —(CH2)2—, —(CH2)3—, —(CH2)2CH(CH3)—, —OCH2CH(CH3)—, —O(CH2)2CH(CH3)—, —O(CH2)3—, —O(CH2)4—, and —S(CH2)3—.

### Claim 12 (depends on 1)

A compound according to claim 1, wherein:
R4 is independently selected from the group consisting of: phenyl, 4-F-phenyl, 4-methyl-phenyl, 3,4-dichloro-phenyl, 1-pyrrolyl, 1-piperidinyl, 4-phenyl-4-OH-piperidin-1-yl, 4-Boc-piperazin-1-yl, 4-Cbz-1-piperazinyl, and
and
L is independently selected from the group consisting of: -(1,2-phenylene)-CH2—, -(1,3-phenylene)-CH2—, -(1,4-phenylene)-CH2—, -(1,3-phenylene)-CH(CH3)—, —O-(1,4-phenylene)-CH2—, -(1,2-phenylene)-O(CH2)3—, -(1,3-phenylene)-O(CH2)3—, -(1,4-phenylene)-O(CH2)3—, —O-(1,4-phenylene)-O(CH2)3—,
alternatively, R4-L- is

### Claim 13 (depends on 1)

A compound according to claim 1, wherein the compound is selected from the exemplified examples, or a stereoisomer, a tautomer, or a pharmaceutically acceptable salt thereof.

### Claim 14 (depends on 1)

A pharmaceutical composition, comprising: a pharmaceutically acceptable carrier and a compound of claim 1.
